Xiromerisiou G - Search Results

1

A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.

Krüger R, Sharma M, Riess O, Gasser T, Van Broeckhoven C, Theuns J, Aasly J, Annesi G, Bentivoglio AR, Brice A, Djarmati A, Elbaz A, Farrer M, Ferrarese C, Gibson JM, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Klein C, Lambert JC, Lesage S, Lin JJ, Lynch T, Mellick GD, de Nigris F, Opala G, Prigione A, Quattrone A, Ross OA, Satake W, Silburn PA, Tan EK, Toda T, Tomiyama H, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Maraganore DM; Genetic Epidemiology of Parkinson's disease consortium. Krüger R, et al. Among authors: xiromerisiou g. Neurobiol Aging. 2011 Mar;32(3):548.e9-18. doi: 10.1016/j.neurobiolaging.2009.11.021. Epub 2009 Dec 24. Neurobiol Aging. 2011. PMID: 20036034 Free PMC article.

2

Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Argyriou AA, Dermitzakis EV, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Vikelis M. Argyriou AA, et al. Among authors: xiromerisiou g. J Clin Med. 2023 Apr 29;12(9):3218. doi: 10.3390/jcm12093218. J Clin Med. 2023. PMID: 37176658 Free PMC article.

3

Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson's Disease Patients and Healthy Controls.

Georgoula M, Ntavaroukas P, Androutsopoulou A, Xiromerisiou G, Kalala F, Speletas M, Asprodini E, Vasilaki A, Papoutsopoulou S. Georgoula M, et al. Among authors: xiromerisiou g. Int J Mol Sci. 2024 Feb 1;25(3):1791. doi: 10.3390/ijms25031791. Int J Mol Sci. 2024. PMID: 38339069 Free PMC article.

4

Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Vikelis M, Dermitzakis EV, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Rikos D, Argyriou AA. Vikelis M, et al. Among authors: xiromerisiou g. J Clin Med. 2023 Jul 6;12(13):4526. doi: 10.3390/jcm12134526. J Clin Med. 2023. PMID: 37445560 Free PMC article.

5

Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine.

Dermitzakis EV, Vikelis M, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P, Rikos D, Argyriou AA. Dermitzakis EV, et al. Among authors: xiromerisiou g. J Clin Med. 2024 Jan 10;13(2):386. doi: 10.3390/jcm13020386. J Clin Med. 2024. PMID: 38256516 Free PMC article.

6

Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up.

Xiromerisiou G, Lampropoulos IC, Dermitzakis EV, Vikelis M, Marogianni C, Mysiris D, Argyriou AA. Xiromerisiou G, et al. Toxins (Basel). 2023 Aug 31;15(9):539. doi: 10.3390/toxins15090539. Toxins (Basel). 2023. PMID: 37755965 Free PMC article.

7

IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury.

Hadjigeorgiou GM, Paterakis K, Dardiotis E, Dardioti M, Aggelakis K, Tasiou A, Xiromerisiou G, Komnos A, Zintzaras E, Scarmeas N, Papadimitriou A, Karantanas A. Hadjigeorgiou GM, et al. Among authors: xiromerisiou g. Neurology. 2005 Oct 11;65(7):1077-82. doi: 10.1212/01.wnl.0000178890.93795.0e. Neurology. 2005. PMID: 16217062

8

Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.

Hadjigeorgiou GM, Xiromerisiou G, Gourbali V, Aggelakis K, Scarmeas N, Papadimitriou A, Singleton A. Hadjigeorgiou GM, et al. Among authors: xiromerisiou g. Mov Disord. 2006 Apr;21(4):534-9. doi: 10.1002/mds.20752. Mov Disord. 2006. PMID: 16250025

9

The human prion gene M129V polymorphism is not associated with idiopathic Parkinson's disease in three distinct populations.

Scholz SW, Xiromerisiou G, Fung HC, Eerola J, Hellström O, Papadimitriou A, Hadjigeorgiou GM, Tienari PJ, Fernandez HH, Mandel R, Okun MS, Gwinn-Hardy K, Singleton AB. Scholz SW, et al. Among authors: xiromerisiou g. Neurosci Lett. 2006 Mar 13;395(3):227-9. doi: 10.1016/j.neulet.2005.10.081. Epub 2005 Nov 18. Neurosci Lett. 2006. PMID: 16298483

10

Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium.

Paisán-Ruíz C, Evans EW, Jain S, Xiromerisiou G, Gibbs JR, Eerola J, Gourbali V, Hellström O, Duckworth J, Papadimitriou A, Tienari PJ, Hadjigeorgiou GM, Singleton AB. Paisán-Ruíz C, et al. Among authors: xiromerisiou g. J Med Genet. 2006 Feb;43(2):e9. doi: 10.1136/jmg.2005.036889. J Med Genet. 2006. PMID: 16467219 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page